Literature DB >> 29846029

A novel use of cardiac resynchronization therapy-defibrillator device in hypertrophic cardiomyopathy.

Serkan Cay1, Ozcan Ozeke1, Firat Ozcan1, Dursun Aras1, Serkan Topaloglu1.   

Abstract

Dual-chamber implantable cardioverter-defibrillator is generally used in patients with atrioventricular block and hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. In the current case, a cardiac resynchronization therapy-defibrillator device was implanted in a patient with non-obstructive hypertrophic cardiomyopathy with preserved ejection fraction and atrioventricular block to achieve both more physiological pacing and life-threatening ventricular arrhythmia management.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CRT-D; His bundle pacing; hypertrophic cardiomyopathy

Mesh：

Year:  2018        PMID： 29846029      PMCID： PMC6931796          DOI： 10.1111/anec.12559

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


  6 in total

1.  A novel use of cardiac resynchronization therapy-defibrillator device in hypertrophic cardiomyopathy.

Authors:  Serkan Cay; Ozcan Ozeke; Firat Ozcan; Dursun Aras; Serkan Topaloglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-05-30       Impact factor: 1.468

2.  Optimized pacing mode for hypertrophic cardiomyopathy: Impact of ECG fusion during pacing.

Authors:  Antonio Berruezo; Diego Penela; Felip Burgos; Reinder Evertz; Juan Fernández-Armenta; Josep Roca; Ada Doltra; Juan Acosta; Antonio Francino; Marta Sitges; Xavi Alsina; Augusto Ordoñez; Roger Villuendas; Ramón Brugada; Lluis Mont; Josep Brugada
Journal:  Heart Rhythm       Date:  2015-01-23       Impact factor: 6.343

3.  Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.

Authors:  Amalie C Thavikulwat; Todd T Tomson; Bradley P Knight; Robert O Bonow; Lubna Choudhury
Journal:  J Cardiovasc Electrophysiol       Date:  2016-06-01

Review 4.  Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Heart Rhythm       Date:  2016-01-01       Impact factor: 6.343

Review 5.  Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

Authors:  Claude Daubert; Fredrik Gadler; Philippe Mabo; Cecilia Linde
Journal:  Europace       Date:  2018-06-01       Impact factor: 5.214

6.  Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.

Authors:  Pier D Lambiase; Michael R Gold; Margaret Hood; Lucas Boersma; Dominic A M J Theuns; Martin C Burke; Raul Weiss; Andrea M Russo; Stefan Kääb; Bradley P Knight
Journal:  Heart Rhythm       Date:  2016-01-06       Impact factor: 6.343
  6 in total
  1 in total

1.  A novel use of cardiac resynchronization therapy-defibrillator device in hypertrophic cardiomyopathy.

Authors:  Serkan Cay; Ozcan Ozeke; Firat Ozcan; Dursun Aras; Serkan Topaloglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-05-30       Impact factor: 1.468
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.